AEP
58
2
CFG
38
-2
LYB
46
-4
RF
51
-2
HP
41
-4
VLO
40
-5
NKE
46
12
PYPL
43
-4
VNO
57
-2
VRSN
53
-2
STZ
63
10
PCG
80
3
VMC
57
-3
TXN
50
-3
SO
66
2
AA
41
-4
LH
48
-2
TDC
59
10
NAVI
55
-2
UPS
55
-6
AEP
58
2
CFG
38
-2
LYB
46
-4
RF
51
-2
HP
41
-4
VLO
40
-5
NKE
46
12
PYPL
43
-4
VNO
57
-2
VRSN
53
-2
STZ
63
10
PCG
80
3
VMC
57
-3
TXN
50
-3
SO
66
2
AA
41
-4
LH
48
-2
TDC
59
10
NAVI
55
-2
UPS
55
-6
Financhill
Back

First Trust Financials AlphaDEX® ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
66

FXO
First Trust Financials AlphaDEX® ETF

Last Price:
51.45
Seasonality Move:
1.58%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
66
First Trust Financials AlphaDEX® ETF (FXO) is a Buy

Is First Trust Financials AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Financials AlphaDEX® ETF [FXO] share price is $51.46. The Score for FXO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • FXO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FXO Stock Price Chart

What is First Trust Financials AlphaDEX® ETF's stock price today?

  • The First Trust Financials AlphaDEX® ETF share price today is $51.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FXO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

FXO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.51 Buy
Relative Strength Index (14 RSI): 62.39 Buy
Chaikin Money Flow: 3339 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.48 - 51.04) Buy
Bollinger Bands (100): (46.05 - 49.77) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

FXO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.49 Buy
20-day SMA: 50.43 Buy
50-day SMA: 49.47 Buy
200-day SMA: 46.09 Buy
8-day EMA: 50.81 Buy
20-day EMA: 50.28 Buy
50-day EMA: 49.35 Buy
200-day EMA: 46.2 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

First Trust Financials AlphaDEX® ETF Earnings Growth & FXO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

First Trust Financials AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):